RELX PLC stock slides again in London — buyback details and the Feb 12 results date to watch
22 January 2026
1 min read

RELX PLC stock slides again in London — buyback details and the Feb 12 results date to watch

London, Jan 22, 2026, 09:30 GMT — Regular session.

  • RELX shares slipped 1.1% in early trading, staying just above their 52-week low.
  • The company has continued purchasing shares daily as part of its ongoing buyback program.
  • The next major event for investors is RELX’s full-year results, set for release in February.

RELX (REL.L) shares dropped 1.1% to 2,937 pence Thursday morning, hovering just above their 52-week low of 2,928 pence. 1

The decline is significant as the company approaches its annual earnings report, with investors keen to catch any shifts in its stance on growth and cash returns. RELX’s financial calendar lists its full-year results for the period ending Dec. 31, 2025, scheduled for release on Feb. 12. 2

RELX revealed another batch of buybacks late Wednesday, announcing it acquired 319,226 shares via UBS AG’s London branch, which will be held as treasury stock. The shares were bought at prices ranging from 2,930 to 2,998 pence each. 3

A filing the day before revealed a nearly identical move: RELX repurchased 314,016 shares on Jan. 20 via UBS, once again placing the stock into treasury. 4

Treasury shares are stocks a company has bought back and holds on its books. These shares can be cancelled or later allocated for purposes such as employee compensation plans, while meanwhile they lower the free float.

Buybacks can boost earnings per share by cutting the number of shares outstanding, and they often provide some support on weaker sessions. But alone, they won’t turn around concerns if investors begin to fear slower growth.

RELX provides subscription and transaction-based info products alongside analytics tools for business, government, and research clients. Its offerings include the Elsevier scientific publishing division and data-driven products tailored for risk and legal sectors.

Shares slipped Thursday, settling close to the low end of their 12-month range following a steep drop from recent peaks. This puts the market on edge, primed for a more volatile response to upcoming data than it might normally show.

Buybacks won’t protect the stock. Should the Feb. 12 update reveal weaker momentum or conservative guidance for 2026, the shares might retest — and fall below — that recent low once more.

Traders are keeping an eye on whether RELX continues to report steady buybacks in the coming days. But the real focus remains on Feb. 12, when the company releases its full-year results along with any guidance or updates on capital returns.

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Future plc snaps up SheerLuxe for £39.9m as buyback rolls on and Fidelity lifts stake
Previous Story

Future plc snaps up SheerLuxe for £39.9m as buyback rolls on and Fidelity lifts stake

Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data
Next Story

Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data

Go toTop